Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Recruiting now · Phase 2

Conditions studied: Epilepsies, Partial

In brief

To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures

Key facts

Study ID

NCT06590896

Run by

Ono Pharmaceutical Co., Ltd.

People needed

100

Starts

2022-11-04

Expected to finish

2027-01-31

Last updated by the study team

2025-06-03

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects completed Study YKP3089C035 by SK Life Science.

You may not qualify if…

• Subjects that have previously discontinued for any reason from the Core study (YKP3089C035).
• Any significant changes to the medical history of the subject that in the opinion of the investigator, could affect the safety of the subject.

Where it is running

• Ehime University Hospital — Ehime, Japan (enrolling)
• Department of Neurology and Stroke Center, Southern Tohoku Clinic. — Fukushima, Japan (enrolling)
• Hiroshima University Hospital — Hiroshima, Japan (enrolling)
• NHO Kure Medical Center and Chugoku Cancer Center — Hiroshima, Japan (enrolling)
• Asahikawa Medical University Hospital — Hokkaido, Japan (enrolling)
• Itami City Hospital — Hyōgo, Japan (enrolling)
• JA-Ibaraki Tsuchiura Kyodo General Hospital — Ibaraki, Japan (enrolling)
• University of Tsukuba Hospital — Ibaraki, Japan (enrolling)
• Kagoshima University Hospital — Kagoshima, Japan (enrolling)
• Tanaka Neurosurgical Clinic — Kagoshima, Japan (enrolling)
• St. Marianna University School of Medicine Hospital — Kanagawa, Japan (enrolling)
• Yokohama City University Hospital — Kanagawa, Japan (enrolling)
• Kumamoto Ezuko Rehabilitation Medical Center — Kumamoto, Japan (enrolling)
• NHO Nagasaki Medical Center — Nagasaki, Japan (enrolling)
• Koide Clinic of Epilepsy and Neurological Disorders — Osaka, Japan (enrolling)
• Osaka University Hospital — Osaka, Japan (enrolling)
• Shintokukai Nii Neurosurgery and Psychiatry Clinic — Osaka, Japan (enrolling)
• Ochiai Brain Clinic — Saitama, Japan (enrolling)
• TMG ASAKA Medical Center — Saitama, Japan (enrolling)
• Sakurai Clinic — Shiga, Japan (enrolling)
• NHO Shizuoka Institute of Epilepsy and Neurological Disorders — Shizuoka, Japan (enrolling)
• Seirei Hamamatsu General Hospital — Shizuoka, Japan (enrolling)
• Seirei Mikatahara General Hospital — Shizuoka, Japan (enrolling)
• Jichi Medical University Hospital — Tochigi, Japan (enrolling)
• Tokushima University Hospital — Tokushima, Japan (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.